These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 6177949)

  • 1. Cardiovascular properties of a new cardiotonic agent: MDL 17,043 (1.3-dihydro-4-methyl-5-[4-(methylthio)-benzoyl]-2H-imidazol-2-one).
    Dage RC; Roebel LE; Hsieh CP; Weiner DL; Woodward JK
    J Cardiovasc Pharmacol; 1982; 4(3):500-8. PubMed ID: 6177949
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiovascular properties of a new cardiotonic agent, MDL 19205.
    Dage RC; Roebel LE; Hsieh CP; Woodward JK
    J Cardiovasc Pharmacol; 1984; 6(1):35-42. PubMed ID: 6199609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular effects of the new cardiotonic agent 1,2-dihydro-6-methyl-2-oxo-5-(imidazo[1,2-a]pyridin-6-yl)-3-pyridine carbonitrile hydrochloride monohydrate. 2nd communication: studies in dogs.
    Ohhara H; Ogawa T; Takeda M; Katoh H; Daiku Y; Igarashi T
    Arzneimittelforschung; 1989 Jan; 39(1):38-45. PubMed ID: 2719742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro and in vivo assessment of the cardiovascular effects of the cardiotonic drug MDL 19205.
    Roebel LE; Dage RC; Cheng HC; Woodward JK
    J Cardiovasc Pharmacol; 1984; 6(1):43-9. PubMed ID: 6199610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of the cardiovascular activities of a new cardiotonic agent, MDL 17043 (1,3-dihydro-4-methyl-5-[4-(methylthio)-benzoyl]-2H-imidazole-2-one).
    Roebel LE; Dage RC; Cheng HC; Woodward JK
    J Cardiovasc Pharmacol; 1982; 4(5):721-9. PubMed ID: 6182401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 4-Aroyl-1,3-dihydro-2H-imidazol-2-ones, a new class of cardiotonic agents.
    Schnettler RA; Dage RC; Grisar JM
    J Med Chem; 1982 Dec; 25(12):1477-81. PubMed ID: 7154009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacology of LY175326: a potent cardiotonic agent with vasodilator activities.
    Hayes JS; Pollock GD; Wilson H; Bowling N; Robertson DW
    J Pharmacol Exp Ther; 1985 May; 233(2):318-26. PubMed ID: 3999023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Positive inotropic therapy for short-term support and long-term management of patients with congestive heart failure: hemodynamic effects and clinical efficacy of MDL 17,043.
    Uretsky BF; Valdes AM; Reddy PS
    Circulation; 1986 Mar; 73(3 Pt 2):III219-29. PubMed ID: 2935328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential effects of sulmazole (AR-L 115 BS) on contractile force and cyclic AMP levels in canine ventricular muscle: comparison with MDL 17,043.
    Endoh M; Yanagisawa T; Morita T; Taira N
    J Pharmacol Exp Ther; 1985 Jul; 234(1):267-73. PubMed ID: 2989507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiovascular pharmacology of 6-[4-(4'-pyridyl)aminophenyl]-4,5-dihydro-3(2H)-pyridazinone hydrochloride, a novel and potent cardiotonic agent with vasodilator properties.
    Narimatsu A; Kitada Y; Satoh N; Suzuki R; Okushima H
    Arzneimittelforschung; 1987 Apr; 37(4):398-406. PubMed ID: 3606694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiovascular effects of (2RS,3SR)- 2-aminomethyl-2,3,7,8-tetrahydro-2,3,5,8,8-pentamethyl-6H-furo- [2,3-e]indol-7-one hydrochloride (UK-1745), a novel cardiotonic agent with vasodilatory and antiarrhythmic properties.
    Uchida Y; Kawada M; Sawanobori K; Sonoki H; Inoue K; Mizuno K; Itou T; Tabunoki Y; Tsukamoto M; Ohashi Y; Kyotani Y; Shimizu N; Fujii M; Nakamura M
    Arzneimittelforschung; 1998 Mar; 48(3):219-31. PubMed ID: 9553677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of oxyphenamone, a new inodilator, on cardiac hemodynamics in normal rat, cat and dog].
    Fan LL; Sun LH; Li J
    Yao Xue Xue Bao; 1997 Oct; 32(10):744-9. PubMed ID: 11596216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiac electrophysiologic and hemodynamic activity of pimobendan (UD-CG 115 BS), a new inotropic agent.
    Kitzen JM; Lynch JJ; Driscoll EM; Lucchesi BR
    J Pharmacol Exp Ther; 1988 Mar; 244(3):929-39. PubMed ID: 3252039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute hemodynamic response to intravenous enoximone: an animal study and preliminary report in infants after cardiac surgery.
    Schranz D; Huth R; Dahm M; Iversen S; Hein E; Stopfkuchen H; Jüngst BK
    J Cardiovasc Pharmacol; 1989; 14 Suppl 1():S62-8. PubMed ID: 2480488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular pharmacology of ASL-7022, a novel catecholamine. I. Inotropic, chronotropic and pressor actions.
    Gorczynski RJ
    J Pharmacol Exp Ther; 1982 Oct; 223(1):7-11. PubMed ID: 7120130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiac and hemodynamic effects of intravenous R 80122, a new phosphodiesterase III inhibitor, in anesthetized and awake dogs.
    Van de Water A; d'Aubioul J; Van Gerven W; de Chaffoy de Courcelles D; Freyne E; Xhonneux R; Reneman RS; Janssen PA
    Arch Int Pharmacodyn Ther; 1992; 316():60-74. PubMed ID: 1530374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The cardiovascular pharmacology of the antibiotic ionophore Ro 2-2985 (X537A).
    Osborne MW; Wenger JJ; Zanko MT
    J Pharmacol Exp Ther; 1977 Jan; 200(1):195-206. PubMed ID: 833757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of AR-L 115 BS, a new cardiotonic compound, on cardiac contractility, heart rate and blood pressure in anaesthetized and conscious animals.
    Diederen W; Kadatz R
    Arzneimittelforschung; 1981; 31(1a):146-50. PubMed ID: 7195208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro and in vivo studies of 3,4-dihydro-6-[4-(3,4-dimethoxybenzoyl)-1-piperazinyl]-2(1H)- quinolinone (OPC-8212), a novel positive inotropic drug, in various animals.
    Yamashita S; Hosokawa T; Kojima M; Mori T; Yabuuchi Y
    Arzneimittelforschung; 1984; 34(3A):342-6. PubMed ID: 6331464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies on the mechanism of the cardiotonic activity of MDL 19205: effects on several biochemical systems.
    Kariya T; Wille LJ; Dage RC
    J Cardiovasc Pharmacol; 1984; 6(1):50-5. PubMed ID: 6199611
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.